Hepatitis C Virus Medicines

Product Details:

Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus genotype 1. Some evidence also supports use in HCV genotype 3 and 4.

Product Details:

• Ledipasvir and Sofosbuvir Tablets is a medication used to treat hepatitis C.
• It is a combination pill containing Sofosbuvir plus Ledipasvir.
• It is used with or without ribavirin to treat chronic (lasting a long time) Hepatitis C genotype 1, 4, 5 or 6 infection, and for some people with genotype 3.

 

Product Details:

Hepcvir L is a medication used to treat hepatitis C.It is a combination pill containing Sofosbuvir plus Ledipasvir. It is used with or without ribavirin to treat chronic (lasting a long time) Hepatitis C genotype 1, 4, 5 or 6 infection, and for some people with genotype 3.

Product Details:

Product Details:

Ledipasvir 90mg And Sofosbuvir 400mg Tablets is a medication used to treat hepatitis C.
It is a combination pill containing Sofosbuvir plus Ledipasvir. It is used with or without ribavirin to treat chronic (lasting a long time) Hepatitis C genotype 1, 4, 5 or 6 infection, and for some people with genotype 3.

Product Details:

• Sofosbuvir 400 mg Velpatasvir 100 mg Tablets is the global oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. VELPANAT is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated). In those with advanced cirrhosis (decompensated), VELPANAT is used with ribavirin.

Therapeutic indications

• Velpanat is indicated for the treatment of adult patients with chronic Hepatitis C Virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
• With or without cirrhosis or with compensated cirrhosis
• With decompensated cirrhosis for use in combination with Ribavirin

Product Details:

Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus genotype 1. Some evidence also supports use in HCV genotype 3 and 4.

Additional Information:

• Packaging Details: 28 Tablets in a bottle

Product Details:

Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus genotype 1. Some evidence also supports use in HCV genotype 3 and 4.

Additional Information:

• Packaging Details: 28 tablets in a bottle

Product Details:

• We are offering Sofosbuvir Tablets 400 mg to our client. Sofosbuvir (brand names , Hepcinat, EHEP,''Resof, Hepcvir,SoviHep) is a nucleotide analog used in combination with other drugs for the treatment of hepatitis C virus (HCV) infection. It has been marketed since 2013. Compared to previous treatments, sofosbuvir-based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy. Sofosbuvir allows most patients to be treated successfully without the use of peginterferon, an injectable drug with severe side effects that is a key component of older drug combinations for the treatment of HCV. We can also supply the Sofosbuvir API.

Additional Information:

• Packaging Details: Export Worthy Packing

Product Details:

Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six.